Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_assertion type Assertion NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_head.
- NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_assertion wasGeneratedBy ECO_0000203 NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_provenance.
- NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_assertion wasDerivedFrom befree-20150227 NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_provenance.
- NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_assertion SIO_000772 18690645 NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_provenance.
- NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_assertion evidence source_evidence_literature NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_provenance.
- NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_assertion description "[The CD44 variants modified by the sialyl Lewis a and sialyl Lewis x glycotopes are expected to have dual functions, serving as ligands for vascular selectins, and simultaneously having binding activity to vascular bed hyaluronate, and are expected to figure heavily in cancer metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414758.RA2H2iPzvIXv1ikVycSZsJfGdg5f_rdJggGE5pCer1zMU130_provenance.